NCMA Welcomes New Member – Novo Nordisk
July 26, 2021
On July 22, 2021, the NCMA Board of Directors approved an application from Novo Nordisk.
Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight (8) countries, and affiliates or offices in five (5) countries.
Novo Nordisk U.S. is headquartered in Plainsboro, NJ with operations in seven (7) states. In North Carolina the company operates two (2) biomanufacturing operations in Clayton and one (1) in Durham. The company has 1400 employees in North Carolina.
Shaylah Nunn Jones, Novo Nordisk’s Government and Public Affairs Lead, will serve as NCMA’s principal contact with the company.
Please join NCMA’s Board of Directors and staff in welcoming Novo Nordisk to the Alliance.
